Clinical Trial Update: Efficacy Trial on Meningococcal B Vaccine for Preventing Gonorrhea Infections [Phase 3]

View source ↗

Summary

Phase 3 efficacy trial evaluating a meningococcal B vaccine for preventing gonorrhea infections. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gonorrhea

Drugs mentioned

• Meningococcal B vaccine (Meningococcal B vaccine)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Gonorrhea, Sexually Transmitted Infection | Phase 3 | Status: ACTIVE_NOT_RECRUITING